Showing results (411-420 of 572) with videos related to

Sort By:
Pageof 58
Genes, Chromosomes & Cancer|July 1, 1990
Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11)M Thangavelu, O Olopade, E Beckman, et al.
Blood|November 1, 1987
Association of a chromosomal 3;21 translocation with the blast phase of chronic myelogenous leukemiaC M Rubin, R A Larson, M A Bitter, et al.
HIV Medicine|March 25, 2014
Prevalence of human papillomavirus in men who have sex with men in the era of an effective vaccine; a call to actC Sadlier, D Rowley, D Morley, et al.
Transplantation and Cellular Therapy|August 27, 2025
Peripheral Blood Tumor Associated Cell-Free DNA Testing As a Predictor for Relapse Post-Allogeneic Stem Cell Transplant for AMLVanisha Patel, Maciej Kabat, Andrew Ip, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 1994
Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocationsG Nucifora, C R Begy, H Kobayashi, et al.
Genes, Chromosomes & Cancer|August 1, 1993
Do terminal deletions of 11q23 exist? Identification of undetected translocations with fluorescence in situ hybridizationH Kobayashi, R Espinosa, M J Thirman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 15, 2011
Evaluation of oral beclomethasone dipropionate for prevention of acute graft-versus-host diseasePaul J Martin, Terry Furlong, Scott D Rowley, et al.
Genes, Chromosomes & Cancer|September 1, 1989
An (8;14)(q24;q11) translocation involving the T-cell receptor alpha-chain gene and the MYC oncogene 3' region in a B-cell lymphomaJ K Park, T W McKeithan, M M Le Beau, et al.
Mutation Research|April 1, 1989
Chromosomal sensitivity of lymphocytes from individuals with therapy-related acute nonlymphocytic leukemiaJ L Schwartz, T Karrison, M M Le Beau, et al.
Bone Marrow Transplantation|May 19, 2019
A phase I/II study of escalating doses of thalidomide in conjunction with bortezomib and high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myelomaNoa Biran, Scott D Rowley, David H Vesole, et al.
Pageof 58